Scholars@Duke publication: P2856 Cumulative meta-analysis of survival with platelet glycoprotein IIb/IIIa antagonists for percutaneous coronary interventions

P2856 Cumulative meta-analysis of survival with platelet glycoprotein IIb/IIIa antagonists for percutaneous coronary interventions

Publication , Conference

KONG, D

Published in: European Heart Journal

March 2003

Published version (DOI) Publisher Link

Duke Scholars

Author David Franklin Kong Medicine, Cardiology

Author Victor Hasselblad Biostatistics & Bioinformatics, Division of Biostatistics

Author James Enlou Tcheng Medicine, Cardiology

Published In

European Heart Journal

DOI

10.1016/s0195-668x(03)95634-x

ISSN

0195-668X

Publication Date

March 2003

Volume

Issue

Start / End Page

544 / 544

Publisher

Elsevier BV

Related Subject Headings

Cardiovascular System & Hematology
3202 Clinical sciences
3201 Cardiovascular medicine and haematology
1103 Clinical Sciences
1102 Cardiorespiratory Medicine and Haematology

Citation

APA

Chicago

ICMJE

MLA

NLM

KONG, D. (2003). P2856 Cumulative meta-analysis of survival with platelet glycoprotein IIb/IIIa antagonists for percutaneous coronary interventions. In European Heart Journal (Vol. 24, pp. 544–544). Elsevier BV. https://doi.org/10.1016/s0195-668x(03)95634-x

KONG, D. “P2856 Cumulative meta-analysis of survival with platelet glycoprotein IIb/IIIa antagonists for percutaneous coronary interventions.” In European Heart Journal, 24:544–544. Elsevier BV, 2003. https://doi.org/10.1016/s0195-668x(03)95634-x.

KONG D. P2856 Cumulative meta-analysis of survival with platelet glycoprotein IIb/IIIa antagonists for percutaneous coronary interventions. In: European Heart Journal. Elsevier BV; 2003. p. 544–544.

KONG, D. “P2856 Cumulative meta-analysis of survival with platelet glycoprotein IIb/IIIa antagonists for percutaneous coronary interventions.” European Heart Journal, vol. 24, no. 5, Elsevier BV, 2003, pp. 544–544. Crossref, doi:10.1016/s0195-668x(03)95634-x.

KONG D. P2856 Cumulative meta-analysis of survival with platelet glycoprotein IIb/IIIa antagonists for percutaneous coronary interventions. European Heart Journal. Elsevier BV; 2003. p. 544–544.

Published In

European Heart Journal

DOI

10.1016/s0195-668x(03)95634-x

ISSN

0195-668X

Publication Date

March 2003

Volume

Issue

Start / End Page

544 / 544

Publisher

Elsevier BV

Related Subject Headings

Cardiovascular System & Hematology
3202 Clinical sciences
3201 Cardiovascular medicine and haematology
1103 Clinical Sciences
1102 Cardiorespiratory Medicine and Haematology